BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10980166)

  • 21. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
    De Brucker K; De Cremer K; Cammue BP; Thevissen K
    Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
    Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
    Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
    Vila TV; Chaturvedi AK; Rozental S; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7611-20. PubMed ID: 26416861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of nucleic acid biosynthesis makes little difference to formation of amphotericin B-tolerant persisters in Candida albicans biofilm.
    Sun J; Liu X; Jiang G; Qi Q
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1627-33. PubMed ID: 25547355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
    J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B.
    Baillie GS; Douglas LJ
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2146-9. PubMed ID: 9687427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
    Jia W; Zhang H; Li C; Li G; Liu X; Wei J
    BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against
    Raut JS; Bansode BS; Jadhav AK; Karuppayil SM
    J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of Candida albicans biofilms to antifungal agents in vitro.
    Hawser SP; Douglas LJ
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2128-31. PubMed ID: 8540729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
    Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
    Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
    J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition.
    Rodrigues CF; Rodrigues ME; Henriques M
    Biofouling; 2018 May; 34(5):569-578. PubMed ID: 29798695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans.
    De Zoysa GH; Glossop HD; Sarojini V
    Eur J Med Chem; 2018 Feb; 146():344-353. PubMed ID: 29407961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of fresh garlic extract on Candida albicans biofilms.
    Shuford JA; Steckelberg JM; Patel R
    Antimicrob Agents Chemother; 2005 Jan; 49(1):473. PubMed ID: 15616341
    [No Abstract]   [Full Text] [Related]  

  • 37. Penetration of Candida biofilms by antifungal agents.
    Al-Fattani MA; Douglas LJ
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3291-7. PubMed ID: 15328087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.
    Khot PD; Suci PA; Miller RL; Nelson RD; Tyler BJ
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3708-16. PubMed ID: 16966398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of dimorphism in the development of Candida albicans biofilms.
    Baillie GS; Douglas LJ
    J Med Microbiol; 1999 Jul; 48(7):671-679. PubMed ID: 10403418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditions for optimal Candida biofilm development in microtiter plates.
    Krom BP; Cohen JB; McElhaney-Feser G; Busscher HJ; van der Mei HC; Cihlar RL
    Methods Mol Biol; 2009; 499():55-62. PubMed ID: 19152039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.